Journal of Clinical Oncology

Trastuzumab: No negative impact on cardiac function

Long-term follow-up results of the NRG Oncology trial NSABP B-31 have shown that the addition of trastuzumab to adjuvant chemotherapy does not negatively affect cardiac function in women with node-positive, human epidermal ...

Jan 03, 2018
popularity1 comments 0

Open, honest talk about death does no harm

Talking through bad news can be good for the doctor-patient relationship—debunking a common myth among patients, according to a study co-authored by the University of Rochester Medical Center's Wilmot Cancer Institute.

Dec 04, 2017
popularity2 comments 0